H. N. Olgun Et Al. , " DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS," The 54th Congress of the International Society of Paediatric Oncology , vol.167, no.1786, Barcelona, Spain, pp.225, 2022
Olgun, H. N. Et Al. 2022. DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS. The 54th Congress of the International Society of Paediatric Oncology , (Barcelona, Spain), 225.
Olgun, H. N., Çeçen, R. E., İnce, D., Kızmazoğlu, D., Baysal, B., Önal, A., ... Özdoğan, Ö.(2022). DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS . The 54th Congress of the International Society of Paediatric Oncology (pp.225). Barcelona, Spain
Olgun, HATİCE Et Al. " DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS," The 54th Congress of the International Society of Paediatric Oncology, Barcelona, Spain, 2022
Olgun, HATİCE N. Et Al. " DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS." The 54th Congress of the International Society of Paediatric Oncology , Barcelona, Spain, pp.225, 2022
Olgun, H. N. Et Al. (2022) . " DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS." The 54th Congress of the International Society of Paediatric Oncology , Barcelona, Spain, p.225.
@conferencepaper{conferencepaper, author={HATİCE NUR OLGUN Et Al. }, title={ DINUTUXIMAB BETA-BASED CHEMO-IMMUNOTHERAPY FOR RELAPSED/REFRACTORY HIGH-RISK NEUROBLASTOMA: PRELIMINARY RESULTS}, congress name={The 54th Congress of the International Society of Paediatric Oncology}, city={Barcelona}, country={Spain}, year={2022}, pages={225} }